Home › Trial NCT00045110
Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma
- Trial IDNCT00045110
- StatusCompleted
- PhasePhase 1/2
- Study typeInterventional
- SponsorNational Cancer Institute (NCI)
- Enrollment136
- Start date2002-08
- ConditionsAdult Anaplastic Astrocytoma · Adult Anaplastic Oligodendroglioma · Adult Giant Cell Glioblastoma · Adult Glioblastoma · Adult Gliosarcoma · Adult Grade I Meningioma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.